Roche Holding AG
RHO5
Company Profile
Business description
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Contact
Grenzacherstrasse 124
Basel4070
CHET: +41 616881111
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
103,249
Stocks News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,660.30 | 22.50 | 0.26% |
CAC 40 | 7,773.93 | 5.79 | -0.07% |
DAX 40 | 24,051.20 | 117.97 | 0.49% |
Dow JONES (US) | 42,215.73 | 117.03 | 0.28% |
FTSE 100 | 8,745.93 | 29.48 | 0.34% |
HKSE | 23,289.77 | 283.61 | -1.20% |
NASDAQ | 19,175.87 | 74.93 | 0.39% |
Nikkei 225 | 37,965.10 | 467.88 | -1.22% |
NZX 50 Index | 12,418.89 | 137.58 | 1.12% |
S&P 500 | 5,912.17 | 23.62 | 0.40% |
S&P/ASX 200 | 8,434.70 | 24.90 | 0.30% |
SSE Composite Index | 3,347.49 | 15.96 | -0.47% |